ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,074.30
0.40%
US Tech 100
20,886.00
1.02%
Dow Jones
44,898.35
0.43%
Brent Oil
72.455
-1.56%
Bitcoin
96,407.93
0.46%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Navamedic Asa (0FDB)

  7. Navamedic Asa (0FDB) News

0FDB

Navamedic Asa (0FDB)

Navamedic Asa
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0FDB
DateTimeSourceHeadlineSymbolCompany
12/21/202311:29AMPR Newswire (US)Navamedic ASA: Renewed contract signed with Vitaflo International LimitedLSE:0FDBNavamedic Asa
12/13/20231:18PMPR Newswire (US)Navamedic and Orion Corporation sign non-binding term sheet for Flexilev®in EuropeLSE:0FDBNavamedic Asa
11/01/20233:14AMPR Newswire (US)Navamedic ASA: Record high quarter with above 50 percent growthLSE:0FDBNavamedic Asa
10/27/20235:52AMPR Newswire (US)Navamedic ASA: Invitation to 2023 3rd quarter presentationLSE:0FDBNavamedic Asa
08/30/20237:20AMPR Newswire (US)Navamedic ASA - Registration of share capital increaseLSE:0FDBNavamedic Asa
08/18/20236:50AMPR Newswire (US)Navamedic ASA - Mandatory notification of trade by primary insiderLSE:0FDBNavamedic Asa
08/18/20236:27AMPR Newswire (US)NAVAMEDIC ASA: Resolution to increase the share capital in connection with exercise of employee optionsLSE:0FDBNavamedic Asa
08/11/20232:41AMPR Newswire (US)Navamedic ASA: Significant growth across the businessLSE:0FDBNavamedic Asa
08/07/20236:40AMPR Newswire (US)Navamedic ASA: Invitation to 2023 2nd quarter presentationLSE:0FDBNavamedic Asa
06/01/20235:43AMPR Newswire (US)Navamedic ASA: Minutes of Annual General MeetingLSE:0FDBNavamedic Asa
05/31/20238:42AMPR Newswire (US)Updated recommendation by the nomination committee of Navamedic ASALSE:0FDBNavamedic Asa
05/26/20232:23AMPR Newswire (US)Navamedic to own a total of 96.33 per cent of shares in Sensidose following closing of public offerLSE:0FDBNavamedic Asa
05/11/20236:15AMPR Newswire (US)Navamedic ASA: Notice of Annual General MeetingLSE:0FDBNavamedic Asa
05/11/20232:57AMPR Newswire (US)Navamedic ASA Q1 2023: Another strong quarterLSE:0FDBNavamedic Asa
05/10/20233:15AMPR Newswire (US)Navamedic increases the consideration to SEK 8.50 in cash per share in its unconditional public offer and convenes an extraordinary general meeting of Sensidose AktiebolagLSE:0FDBNavamedic Asa
05/08/20235:25AMPR Newswire (US)Navamedic ASA: Invitation to 2023 1st quarter presentationLSE:0FDBNavamedic Asa
04/28/20237:57AMPR Newswire (US)Navamedic ASA: Annual Report for 2022LSE:0FDBNavamedic Asa
04/23/202311:34PMPR Newswire (US)Navamedic ASA: Amended cash offer to acquire Sensidose AB and acquisition of shares in Sensidose ABLSE:0FDBNavamedic Asa
03/29/20232:13AMPR Newswire (US)Navamedic ASA: Recommended cash offer to acquire Sensidose for approximately SEK 75 millionLSE:0FDBNavamedic Asa
02/16/20233:00AMPR Newswire (US)Navamedic ASA: Q4 2022 financial resultsLSE:0FDBNavamedic Asa
02/13/20233:19AMPR Newswire (US)Navamedic ASA: Invitation to 2022 4th quarter presentationLSE:0FDBNavamedic Asa
11/23/20225:30AMPR Newswire (US)Navamedic ASA acquires innovative antibiotic product for hospital use in the Nordic regionLSE:0FDBNavamedic Asa
11/01/20223:43AMPR Newswire (US)Navamedic ASA: Q3 2022 financial resultsLSE:0FDBNavamedic Asa
10/25/202210:01AMPR Newswire (US)Navamedic ASA: Invitation to 2022 third quarter presentationLSE:0FDBNavamedic Asa
10/20/20223:24AMPR Newswire (US)Navamedic ASA launches ForlaxGO® - an innovative on-the-go product for the treatment of constipationLSE:0FDBNavamedic Asa
08/12/20222:48AMPR Newswire (US)Navamedic ASA: Q2 and first half 2022 financial resultsLSE:0FDBNavamedic Asa
08/09/20228:40AMPR Newswire (US)Navamedic ASA: Invitation to 2022 second quarter presentationLSE:0FDBNavamedic Asa
08/04/20228:27AMPR Newswire (US)Navamedic ASA - Exclusive agreement with Vectans Pharma for the unique cold sore treatment product Sitavig®LSE:0FDBNavamedic Asa
07/04/20222:13PMPR Newswire (US)Navamedic ASA: Trading UpdateLSE:0FDBNavamedic Asa
06/02/20228:05AMPR Newswire (US)Navamedic ASA: Minutes of Annual General MeetingLSE:0FDBNavamedic Asa
 Showing the most relevant articles for your search:LSE:0FDB

Your Recent History

BIT
UB87PA
Unicredit Bank
NASDAQI
FDSMBTR
FactSet Global Mobility ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved